サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427885

凍結乾燥注射剤の世界市場レポート 2024

Lyophilized Injectable Drugs Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
凍結乾燥注射剤の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

凍結乾燥注射剤の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には3.3%の年間複合成長率（CAGR）で44億8,000万米ドルに成長すると予想されます。予測期間中に予測される成長は、個別化医療の採用の増加、生物製剤パイプラインの拡大、世界の医療への備えの取り組み、希少疾病用医薬品の需要の高まり、患者のコンプライアンスの重視の高まりによって促進されます。予測期間中に予想される注目すべき動向には、凍結乾燥併用療法における革新、凍結乾燥ワクチンの拡張、品質バイデザイン（QbD）原則の組み込み、救急医療における凍結乾燥薬の応用、凍結乾燥の検証に対する規制の焦点が含まれます。プロセス。

凍結乾燥注射剤市場の予想される急増は、心疾患の有病率の増加によるものです。心臓障害には、弁、心室、動脈、電気システム、全体的なポンプ機能など、心臓の構造と機能に影響を与えるさまざまな状態が含まれます。血栓溶解薬、抗不整脈薬、変力薬、降圧薬などの凍結乾燥注射剤は、さまざまな心臓疾患の治療において重要な役割を果たします。それらの使用は、安定性、利便性、柔軟性、迅速な再構成、生物学的利用能の向上、汚染リスクの軽減などの要因によって決まります。

凍結乾燥注射剤市場の成長は、心臓疾患の世界の増加によってさらに促進されています。たとえば、2023年 5月の疾病管理予防センター（CDC）の報告書では、2021年に冠状動脈性心疾患により375,476人の命が失われたことが強調されました。さらに、2022年 12月のニューヨーク州政府のデータでは、心臓病が原因で次のような症状が生じることが明らかになりました。米国では年間約697,000人が死亡しています。このうち、毎年80万5,000人のアメリカ人が心臓発作を経験しており、そのうち60万5,000人が初発、20万人が以前の心臓発作によるものです。その結果、心疾患の発生率の増加は、予測期間中の凍結乾燥注射剤市場の成長の主要な推進力となります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の凍結乾燥注射剤市場、包装タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 特殊包装
  • ポイントオブケアの再構成
  • 使い捨てバイアル
  • その他の包装タイプ
  • 世界の凍結乾燥注射剤市場、配達の種類別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • シングルステップデバイス
  • マルチステップデバイス
  • プレフィルド希釈剤シリンジ
  • 独自再構成デバイス
  • 世界の凍結乾燥注射剤市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 感染症
  • 自己免疫疾患
  • 代謝状態
  • その他の適応症
  • 世界の凍結乾燥注射剤市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 外来手術センター（ASC）
  • 専門クリニック
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の凍結乾燥注射剤市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の凍結乾燥注射剤市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 凍結乾燥注射剤市場の競合情勢
  • 凍結乾燥注射剤市場の企業プロファイル
    • Pfizer Inc.
    • Hoffmann-La Roche Ltd
    • Merck &Co Inc.
    • Sanofi SA
    • Novo Nordisk A/S

第31章 その他の大手および革新的な企業

  • Becton Dickinson and Company
  • Baxter International Inc.
  • Sandoz
  • Nipro Corporation
  • B. Braun SE
  • Aurobindo Pharmaceuticals
  • Schott AG
  • Zydus Lifesciences
  • Recipharm AB
  • Vetter Pharma-Fertigung GmbH &Co. KG
  • Fresenius Kabi USA LLC
  • Curia Global Inc.
  • CordenPharma International
  • Aristopharma Limited.
  • Accord Healthcare

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13729

Lyophilized injectable drugs, commonly known as freeze-dried drugs, undergo a process called lyophilization to remove water from the medications. This technique involves freezing the drugs and then subjecting them to a vacuum, causing the frozen water to transition directly from a solid to a gas state. Lyophilized injectable drugs offer improvements in bioavailability, stability, solubility, and patient compliance.

These drugs are packaged in various types, including specialty packaging, point-of-care reconstitution, single-use vials, and others. Point-of-care reconstitution involves preparing medication for immediate use by reconstituting a lyophilized drug at the point of administration or patient bedside. Different delivery methods include single-step devices, multi-step devices, prefilled diluent syringes, and proprietary reconstitution devices. These devices are utilized in the treatment of various conditions such as infectious diseases, autoimmune diseases, and metabolic conditions. The end-users of lyophilized injectable drugs encompass hospitals, ambulatory surgery centers (ASCs), specialty clinics, and other healthcare facilities.

The lyophilized injectable drugs market research report is one of a series of new reports from The Business Research Company that provides lyophilized injectable drugs market statistics, including lyophilized injectable drugs industry global market size, regional shares, competitors with a lyophilized injectable drugs market share, detailed lyophilized injectable drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the lyophilized injectable drugs industry. This lyophilized injectable drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lyophilized injectable drugs market size has grown steadily in recent years. It will grow from $3.82 billion in 2023 to $3.93 billion in 2024 at a compound annual growth rate (CAGR) of 3.0%. The growth observed in the historical period can be attributed to several key factors, including the rise in chronic diseases, the expansion of the biopharmaceutical industry, an increasing geriatric population, advancements in clinical practices and trials, and the globalization of pharmaceutical manufacturing. These factors collectively contributed to the growth and development of the healthcare and pharmaceutical sectors during the specified historic period.

The lyophilized injectable drugs market size is expected to see steady growth in the next few years. It will grow to $4.48 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%. The projected growth during the forecast period is driven by the increasing adoption of personalized medicine, the expansion of the biologics pipeline, global health readiness efforts, heightened demand for orphan drugs, and a growing emphasis on patient compliance. Noteworthy trends anticipated in the forecast period encompass innovations in lyophilized combination therapies, the extension of lyophilized vaccines, the incorporation of quality-by-design (QbD) principles, the application of lyophilized drugs in emergency medicine, and regulatory focus on the validation of lyophilization processes.

The anticipated surge in the lyophilized injectable drugs market is attributed to the increasing prevalence of cardiac disorders. Cardiac disorders encompass a diverse range of conditions affecting the heart's structure and function, including valves, chambers, blood arteries, the electrical system, and overall pumping function. Lyophilized injectable drugs, such as thrombolytic agents, antiarrhythmic medications, inotropic agents, and antihypertensive medications, play a crucial role in treating various cardiac disorders. Their usage is driven by factors such as stability, convenience, flexibility, rapid reconstitution, improved bioavailability, and a reduced risk of contamination.

The growth of the lyophilized injectable drugs market is further propelled by the global rise in cardiac disorders. For example, a report from the Centers for Disease Control and Prevention (CDC) in May 2023 highlighted that coronary heart disease claimed the lives of 375,476 individuals in 2021. Additionally, data from the New York government in December 2022 revealed that heart disease results in approximately 697,000 deaths annually in the United States. Of these, 805,000 Americans experience a heart attack each year, with 605,000 being first-time occurrences and 200,000 resulting from previous heart attacks. Consequently, the increasing incidence of cardiac disorders is a key driver for the growth of the lyophilized injectable drugs market during the forecast period.

The escalating incidence of cardiovascular diseases is poised to propel the lyophilized injectable drugs market. Cardiovascular diseases encompass a spectrum of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and heart valve problems. Lyophilized injectable drugs address cardiovascular diseases by providing stable and durable formulations that enhance drug efficacy, ensure precise dosing, and enable convenient administration. This contributes to improved patient outcomes and treatment compliance. In 2022, according to data from the Centers for Disease Control and Prevention (CDC), heart disease accounted for over 659,000 deaths in the United States, representing one in every four fatalities. Specifically, coronary heart disease, the most prevalent type, claimed 375,476 lives in 2021. Therefore, the escalating cases of cardiovascular diseases are expected to drive the lyophilized injectable drugs market forward.

The prevailing trend in the lyophilized injectable drug market is the emphasis on product innovations, with major companies actively pursuing novel drug delivery systems to enhance their market profitability. Notably, in June 2022, Gufic Biosciences Ltd., an India-based pharmaceutical company, introduced Dual Chamber Bags (DCB), a critical innovation for reconstituting lyophilized injectable drugs. These bags offer multiple advantages, including a reduction in the risk of bloodstream infections, ensuring patient safety, and preventing prescription errors.

Leading companies in the lyophilized injectable drug market are channeling their efforts into leveraging innovative technologies, such as non-invasive technology, for the development of lyophilized injectable drugs. Non-invasive technology involves methods or devices that gather information or perform tasks without penetrating the skin or entering bodily orifices. For example, in October 2023, COMSER Pharma, a Spain-based provider of compliance services and freeze-dry pharmaceutical solutions, introduced LyoFlow, an innovative technology for lyophilized injectable drug production. LyoFlow is a disruptive solution enabling real-time, non-invasive extraction of the mass flow in a freeze-drying process, easily integratable into any lyophilization equipment, and facilitating continuous monitoring of product quality throughout the process.

In April 2022, Recipharm AB, a pharmaceutical contract development and manufacturing organization based in Sweden, acquired Vibalogics for an undisclosed amount. This acquisition aims to reinforce the company's position in the biologics market, with a specific focus on manufacturing drug ingredients for novel advanced therapeutic medicinal goods. Vibalogics, a Germany-based manufacturing company, specializes in the production of sophisticated live biological products, operating within the lyophilized injectable drugs market.

Major companies operating in the lyophilized injectable drugs market report are Pfizer Inc., Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi SA, Novo Nordisk A/S, Becton Dickinson and Company, Baxter International Inc., Sandoz, Nipro Corporation, B. Braun SE, Aurobindo Pharmaceuticals, Schott AG, Zydus Lifesciences, Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Fresenius Kabi USA LLC, Vetter Pharma-Fertigung GmbH & Co. KG, CordenPharma International, Aristopharma Limited., Accord Healthcare, Jubilant HollisterStier LLC, Ciron Drugs & Pharmaceuticals Pvt Ltd., MSN Laboratories, Qilu pharmaceutical Co Ltd., Genex Pharma

North America was the largest region in the lyophilized injectable drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyophilized injectable drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lyophilized injectable drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lyophilized injectable drugs market consists of revenue by entities by providing Pre-freezing, primary drying, and secondary drying. The market value includes the value of related goods sold by the service provider or included within the service offering. The lyophilized injectable drugs market also includes sales of ceftriaxone, vancomycin, and meropenem. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lyophilized Injectable Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lyophilized injectable drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lyophilized injectable drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lyophilized injectable drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Packaging Type: Specialty Packaging; Point-Of-Care Reconstitution; Single-Use Vials; Other Packaging Types.
  • 2) By Type of Delivery: Single-Step Devices; Multi-Step Devices; Prefilled Diluent Syringes; Proprietary Reconstitution Devices.
  • 3) By Indication: Infectious Diseases; Autoimmune Diseases; Metabolic Conditions; Other Indications.
  • 4) By End-User: Hospitals; Ambulatory Surgery Centers (ASCs); Specialty Clinics; Other End-Users.
  • Companies Mentioned: Pfizer Inc.; Hoffmann-La Roche Ltd; Merck & Co Inc.; Sanofi SA; Novo Nordisk A/S
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lyophilized Injectable Drugs Market Characteristics

3. Lyophilized Injectable Drugs Market Trends And Strategies

4. Lyophilized Injectable Drugs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Lyophilized Injectable Drugs Market Size and Growth

  • 5.1. Global Lyophilized Injectable Drugs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Lyophilized Injectable Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Lyophilized Injectable Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Lyophilized Injectable Drugs Market Segmentation

  • 6.1. Global Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Specialty Packaging
  • Point-Of-Care Reconstitution
  • Single-Use Vials
  • Other Packaging Types
  • 6.2. Global Lyophilized Injectable Drugs Market, Segmentation By Type of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single-Step Devices
  • Multi-Step Devices
  • Prefilled Diluent Syringes
  • Proprietary Reconstitution Devices
  • 6.3. Global Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Diseases
  • Autoimmune Diseases
  • Metabolic Conditions
  • Other Indications
  • 6.4. Global Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Specialty Clinics
  • Other End-Users

7. Lyophilized Injectable Drugs Market Regional And Country Analysis

  • 7.1. Global Lyophilized Injectable Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Lyophilized Injectable Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Lyophilized Injectable Drugs Market

  • 8.1. Asia-Pacific Lyophilized Injectable Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Lyophilized Injectable Drugs Market

  • 9.1. China Lyophilized Injectable Drugs Market Overview
  • 9.2. China Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Lyophilized Injectable Drugs Market

  • 10.1. India Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Lyophilized Injectable Drugs Market

  • 11.1. Japan Lyophilized Injectable Drugs Market Overview
  • 11.2. Japan Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Lyophilized Injectable Drugs Market

  • 12.1. Australia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Lyophilized Injectable Drugs Market

  • 13.1. Indonesia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Lyophilized Injectable Drugs Market

  • 14.1. South Korea Lyophilized Injectable Drugs Market Overview
  • 14.2. South Korea Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Lyophilized Injectable Drugs Market

  • 15.1. Western Europe Lyophilized Injectable Drugs Market Overview
  • 15.2. Western Europe Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Lyophilized Injectable Drugs Market

  • 16.1. UK Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Lyophilized Injectable Drugs Market

  • 17.1. Germany Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Lyophilized Injectable Drugs Market

  • 18.1. France Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Lyophilized Injectable Drugs Market

  • 19.1. Italy Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Lyophilized Injectable Drugs Market

  • 20.1. Spain Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Lyophilized Injectable Drugs Market

  • 21.1. Eastern Europe Lyophilized Injectable Drugs Market Overview
  • 21.2. Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Lyophilized Injectable Drugs Market

  • 22.1. Russia Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Lyophilized Injectable Drugs Market

  • 23.1. North America Lyophilized Injectable Drugs Market Overview
  • 23.2. North America Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Lyophilized Injectable Drugs Market

  • 24.1. USA Lyophilized Injectable Drugs Market Overview
  • 24.2. USA Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Lyophilized Injectable Drugs Market

  • 25.1. Canada Lyophilized Injectable Drugs Market Overview
  • 25.2. Canada Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Lyophilized Injectable Drugs Market

  • 26.1. South America Lyophilized Injectable Drugs Market Overview
  • 26.2. South America Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Lyophilized Injectable Drugs Market

  • 27.1. Brazil Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Lyophilized Injectable Drugs Market

  • 28.1. Middle East Lyophilized Injectable Drugs Market Overview
  • 28.2. Middle East Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Lyophilized Injectable Drugs Market

  • 29.1. Africa Lyophilized Injectable Drugs Market Overview
  • 29.2. Africa Lyophilized Injectable Drugs Market, Segmentation By Packaging Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Lyophilized Injectable Drugs Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Lyophilized Injectable Drugs Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Lyophilized Injectable Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Lyophilized Injectable Drugs Market Competitive Landscape
  • 30.2. Lyophilized Injectable Drugs Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Hoffmann-La Roche Ltd
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novo Nordisk A/S
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Lyophilized Injectable Drugs Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Baxter International Inc.
  • 31.3. Sandoz
  • 31.4. Nipro Corporation
  • 31.5. B. Braun SE
  • 31.6. Aurobindo Pharmaceuticals
  • 31.7. Schott AG
  • 31.8. Zydus Lifesciences
  • 31.9. Recipharm AB
  • 31.10. Vetter Pharma-Fertigung GmbH & Co. KG
  • 31.11. Fresenius Kabi USA LLC
  • 31.12. Curia Global Inc.
  • 31.13. CordenPharma International
  • 31.14. Aristopharma Limited.
  • 31.15. Accord Healthcare

32. Global Lyophilized Injectable Drugs Market Competitive Benchmarking

33. Global Lyophilized Injectable Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lyophilized Injectable Drugs Market

35. Lyophilized Injectable Drugs Market Future Outlook and Potential Analysis

  • 35.1 Lyophilized Injectable Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Lyophilized Injectable Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Lyophilized Injectable Drugs Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer